Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00036309 · ClinicalTrials.gov registry record · Phase 3
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
A Phase 3 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00036309: Completed Phase 3 study, sponsored by Eli Lilly and Company.
NCT00036309 is a Phase 3 study that has completed, run by Eli Lilly and Company. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00036309, a Phase 3 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.
Interventions
- DRUG Duloxetine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-05 |
| Est. Completion | 2003-07 |
| Phase | Phase 3 |
What the finished NCT00036309 record still lists
NCT00036309 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Duloxetine Hydrochloride is the first listed.
NCT00036309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00036309 about?
NCT00036309 is a clinical study titled "Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder". The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.
What is the current status of trial NCT00036309?
This trial is currently completed. It is a Phase 3 study. The study started on 2002-05. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00036309?
The interventions under investigation include: Duloxetine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00036309?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia